Company profile
CanaFarma Hemp Products Corp.
OTC: CNFHF · Healthcare · Drug Manufacturers - Specialty & Generic
Canadian filerHQ Vancouver, BCReports USD
#815 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
——FH —DQ —GM —SS 18
v0.1 · 5/100 weight · pillars only
↑ revenue growth (YoY), balance-sheet leverage · ↓ disclosure history, workforce scale
Methodology →Revenue TTM
-$513.4k
Rev growth YoY (TTM)
-130.3%
Net income (FY)
-$17.5M
Employees
5
as of 2026-08-29
Market cap
$19.6k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.8M$1.8M2020
Net income-$17.5M-$17.5M2020
Operating income-$10.1M-$10.1M2020
Total assets$6.8M$6.8M2020
Liabilities$6.9M$6.9M2020
Equity-$99.0k-$99.0k2020
Revenue trend
FY2018 – FY2020 · USD
FY18
FY19
FY20
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is CanaFarma Hemp Products Corp.’s revenue?
CanaFarma Hemp Products Corp. booked $1.8M in FY2020 revenue, growing 3030% year over year — faster than 98% of Healthcare companies we track, at a -986.7% net margin.
Peers · Healthcare
Beleave Inc.——Bionik Laboratories Corp.——Nutranomics, Inc.——Spectral Medical Inc31DVolitionRX Ltd40DClearside Biomedical, Inc.——Key facts
CEOPhil Klauder
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersVancouver, BC
ExchangeOTC: CNFHF
Employees5
IPO date2021-04-01
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.